These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. New strategies in the development of thrombolytic agents. Lijnen HR; Collen D Curr Stud Hematol Blood Transfus; 1991; (58):69-72. PubMed ID: 1954777 [No Abstract] [Full Text] [Related]
6. [New thrombolytic agents in myocardial infarction]. Charbonnier B; Lang M; Brochier M Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222 [TBL] [Abstract][Full Text] [Related]
7. In vivo assessment of thrombosis and fibrinolysis during acute myocardial infarction. Jaffe AS; Eisenberg PR; Wilner GD Prog Hematol; 1987; 15():71-89. PubMed ID: 3332392 [No Abstract] [Full Text] [Related]
8. [Pharmacological potentials for activating the fibrinolytic system]. Markwardt F Z Gesamte Inn Med; 1984 May; 39(10):209-13. PubMed ID: 6380126 [TBL] [Abstract][Full Text] [Related]
15. [The fibrinolytic system and its activators]. Seifried E Z Gesamte Inn Med; 1993; 48(6-7):272-82. PubMed ID: 8333223 [TBL] [Abstract][Full Text] [Related]
16. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy. Collen D; Lijnen HR Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451 [TBL] [Abstract][Full Text] [Related]
17. Current concepts in coronary thrombolysis. Eisenberg PR Hematol Oncol Clin North Am; 1992 Oct; 6(5):1161-70. PubMed ID: 1400079 [TBL] [Abstract][Full Text] [Related]
19. Thrombolytic therapy. Collen D; Lijnen HR Ann N Y Acad Sci; 1991; 614():259-69. PubMed ID: 1902640 [No Abstract] [Full Text] [Related]
20. [Role of single chain pro-UK on the initiation and regulation of fibrinolysis]. Arimura H; Kasai S; Nishida M; Suyama T Rinsho Byori; 1989 Apr; Spec No 81():107-17. PubMed ID: 2502639 [No Abstract] [Full Text] [Related] [Next] [New Search]